The CTD² Network and Cancer Systems Biology Consortium organized a virtual symposium series titled “Multidisciplinary Approaches to Understand Cancer Treatment Resistance”. Please join us on 11/16, 11/17, 12/2, 12/16, and 12/17. Click here to view the registration website.
CTD² Resources include "analytical tools" and "reagents" generated by CTD² Network members.
The CTD2 Network develops new approaches to identify novel targets and functionally validate discoveries made from large-scale genomic initiatives, such as The Cancer Genome Atlas (TCGA), Therapeutically Applicable Research to Generate Effective Treatments (TARGET), and the Cancer Genome Characterization Initiative (CGCI), and advance them toward precision medicine.
To accelerate the cancer target discovery, CTD2 aims to disseminate knowledge, data, tools and resources with the scientific community. This page provides a list of materials (including plasmids, cell lines, cell models, etc.) which are generated by CTD2-supported research and are available for use by researchers.